Groundbreaking Antibody Targets EBV, Halting Infections & Complications

Researchers developed a novel antibody targeting the Epstein-Barr virus (EBV), which infects 95% of adults. This breakthrough could prevent related cancers, MS, and severe complications.

Read the full article and join the community discussion on Inimzu.